Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Tong Ren Tang Chinese Medicine Company Limited announced that all proposed resolutions were passed at their Annual General Meeting on June 7, 2024, with overwhelming shareholder support, including the reelection of executive directors and the approval of a final dividend of HK$0.33 per share for the year ended December 31, 2023. Additionally, a general mandate for share issuance and repurchase was approved, along with an extension contingent on these mandates.
For further insights into HK:3613 stock, check out TipRanks’ Stock Analysis page.